Related Experiment Video
Updated: Nov 7, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
Leah K Lambert1,2, Lynda G Balneaves3, A Fuchsia Howard1
1School of Nursing, University of British Columbia, Vancouver, BC V6T 2B5, Canada.
Healthcare providers find challenges in supporting breast cancer survivors with adjuvant endocrine therapy (AET) adherence. Improving care models and system innovations are crucial for better survivorship and reduced mortality.
Area of Science:
- Oncology
- Healthcare Delivery
- Patient Adherence
Background:
- Adherence to adjuvant endocrine therapy (AET) for breast cancer is a significant challenge in survivorship care.
- Suboptimal adherence can impact treatment efficacy and patient outcomes.
Purpose of the Study:
- To explore healthcare providers' (HCPs) experiences and perspectives on providing care to breast cancer survivors on AET.
- To identify social and structural factors influencing AET-related care.
- To gather HCP recommendations for optimizing AET adherence.
Main Methods:
- Individual, in-depth interviews with 14 HCPs.
- Interpretive descriptive approach and relational autonomy theoretical lens.
- Thematic and constant comparative data analysis techniques.
Main Results:
- HCPs focused on careful AET conversations, navigating care transitions, symptom management, and AET discontinuation.
- Key challenges included communication, care coordination, and managing side effects.
- HCPs emphasized the need for sustainable and efficient care models.
Conclusions:
- HCPs are pivotal in educating and supporting women on AET.
- Sustainable healthcare innovations and new models of care are essential to address system gaps.
- Optimizing AET adherence can enhance survivorship care, reduce cancer recurrence, and improve mortality rates.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Drug Therapy
Antianxiety Medications
Kidney Transplant III: Nursing Management
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
